Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Clinical Trial 39751

Decatur, GA 30033


Study Summary:

This XanADu Phase II study in mild Alzheimer's Disease (AD) is to assess the safety, tolerability and efficacy of Xanamem™ in subjects with mild dementia due to Alzheimer's Disease.


Qualified Participants Must:

• Be 50 years of age or older
• Have mild dementia due to probable AD
• Have the availability of a study partner


Qualified Participants May Receive:

May be compensated for time and travel.


Research Site Profile

View Clinic Profile


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.